These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25519886)

  • 21. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
    Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
    PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis.
    Moles R; Nicot C
    Viruses; 2015 Jul; 7(7):4047-74. PubMed ID: 26205403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
    Nakahata S; Morishita K
    J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
    Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
    Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection.
    Mamane Y; Grandvaux N; Hernandez E; Sharma S; Innocente SA; Lee JM; Azimi N; Lin R; Hiscott J
    Oncogene; 2002 Oct; 21(44):6751-65. PubMed ID: 12360402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
    Mortreux F; Gabet AS; Wattel E
    Leukemia; 2003 Jan; 17(1):26-38. PubMed ID: 12529656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype.
    Zane L; Sibon D; Mortreux F; Wattel E
    Front Biosci (Landmark Ed); 2009 Jan; 14(10):3935-41. PubMed ID: 19273324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma.
    Nakahata S; Saito Y; Hamasaki M; Hidaka T; Arai Y; Taki T; Taniwaki M; Morishita K
    Genes Chromosomes Cancer; 2009 Sep; 48(9):768-76. PubMed ID: 19484761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB.
    Jain P; Lavorgna A; Sehgal M; Gao L; Ginwala R; Sagar D; Harhaj EW; Khan ZK
    Retrovirology; 2015 Feb; 12():23. PubMed ID: 25809782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HTLV-1: multistep leukemogenesis of adult T-cell leukemia].
    Fujii M; Higuchi M; Endo K; Takahashi T; Ohhashi M; Tezuka T; Shinohara H; Hirata A; Mori N
    Uirusu; 2002 Jun; 52(1):103-8. PubMed ID: 12227157
    [No Abstract]   [Full Text] [Related]  

  • 33. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma.
    Nicot C
    Am J Hematol; 2005 Mar; 78(3):232-9. PubMed ID: 15726602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.
    Zane L; Sibon D; Capraro V; Galia P; Karam M; Delfau-Larue MH; Gilson E; Gessain A; Gout O; Hermine O; Mortreux F; Wattel E
    Int J Cancer; 2012 Aug; 131(4):821-33. PubMed ID: 21717459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
    Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
    J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
    Forlani G; Abdallah R; Accolla RS; Tosi G
    J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.
    Shigemura T; Shiohara M; Kato M; Furuta S; Kaneda K; Morishita K; Hasegawa H; Fujii M; Gorlach A; Koike K; Kamata T
    J Virol; 2015 Sep; 89(17):9080-9. PubMed ID: 26109726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?
    Bangham CR; Ratner L
    Curr Opin Virol; 2015 Oct; 14():93-100. PubMed ID: 26414684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.
    Yoshida M
    Annu Rev Immunol; 2001; 19():475-96. PubMed ID: 11244044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
    Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
    Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.